CoChat

Cohort profile: design and first results of the Dutch IBD Biobank: a prospective, nationwide biobank of patients with inflammatory bowel disease

Open access
Spekhorst, Lieke M, Imhann, Floris, Festen, Eleonora AM, Bodegraven, Ad A van, Boer, Nanne KH de, Bouma, Gerd, Fidder, Herma H, D’Haens, Geert, Hoentjen, Frank, Hommes, Daan W, Jong, Dirk J de, Löwenberg, Mark, Maljaars, PW Jeroen, Meulen-de Jong, Andrea E van der, Oldenburg, Bas, Pierik, Marieke J, Ponsioen, Cyriel Y, Stokkers, Pieter C, Verspaget, Hein W, Visschedijk, Marijn C, van der Woude, C Janneke, Dijkstra, Gerard, Weersma, Rinse K · 2017 · BMJ Open
Cited by 55

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Purpose: The Dutch IBD Biobank aims to facilitate the discovery of predictors for individual disease course and treatment response in patients with inflammatory bowel disease (IBD). In this paper, we aim to describe the establishment of the Dutch IBD Biobank, including the facilitators and barriers to establishment. Moreover, we aim to provide a complete overview of the content of the Dutch IBD Biobank. Participants: Since 2007, every patient with IBD treated in one of the eight Dutch university medical centres is asked to participate in the Dutch IBD Biobank in which 225 standardised IBD-related data items and biomaterials, such as serum, DNA, biopsies and a stool sample, are collected. Findings to date: As of June 2014, the Dutch IBD Biobank had enrolled 3388 patients with IBD: 2118 Crohn’s disease (62.5%), 1190 ulcerative colitis (35.1%), 74 IBD-unclassified (2.2%) and 6 IBD-indeterminate (0.2%). The inclusion of patients with IBD is ongoing. The quality of the biomaterials is good and serum, DNA and biopsies have been used in newly published studies. Future plans: The genotyping (750 000 genetic variants) of all participants of the Dutch IBD Biobank is currently ongoing, enabling more genetic research. In addition, all participants will start reporting disease activity and outcome measures using an online platform and mobile app .

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmjopen-2017-016695

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 55

Metadata

Authors
Spekhorst, L. M., Imhann, F., Festen, E. A., Bodegraven, A. A. V., Boer, N. K. D., Bouma, G., Fidder, H. H., D’Haens, G., Hoentjen, F., Hommes, D. W., Jong, D. J. D., Löwenberg, M., Maljaars, P. J., Meulen-de Jong, A. E. V. D., Oldenburg, B., Pierik, M. J., Ponsioen, C. Y., Stokkers, P. C., Verspaget, H. W., Visschedijk, M. C., van der Woude, C. J., Dijkstra, G., & Weersma, R. K.
Venue
BMJ Open
Publisher
BMJ
Published
2017-11
Volume
7
Issue
11
Pages
e016695
ISSN
2044-6055 (ISSN-L)
OpenAlex
W2767539938
Cited by
55
References
6
FWCI
2.29
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cohort profile: design and first results of the Dutch IBD Biobank: a prospective, nationwide biobank of patients with inflammatory bowel disease. https://app.cochat.ai/papers/10.1136/bmjopen-2017-016695
The paper
Spekhorst, L. M., Imhann, F., Festen, E. A., Bodegraven, A. A. V., Boer, N. K. D., Bouma, G., Fidder, H. H., D’Haens, G., Hoentjen, F., Hommes, D. W., Jong, D. J. D., Löwenberg, M., Maljaars, P. J., Meulen-de Jong, A. E. V. D., Oldenburg, B., Pierik, M. J., Ponsioen, C. Y., Stokkers, P. C., Verspaget, H. W., . . . Weersma, R. K. (2017). Cohort profile: design and first results of the Dutch IBD Biobank: a prospective, nationwide biobank of patients with inflammatory bowel disease. BMJ Open. https://doi.org/10.1136/bmjopen-2017-016695

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.